- Home
- PRAX vs SVM Comparison
PRAX vs SVM Comparison
Compare PRAX & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- SVM
- Stock Information
- Founded
- PRAX 2015
- SVM N/A
- Country
- PRAX United States
- SVM Canada
- Employees
- PRAX N/A
- SVM N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- PRAX Health Care
- SVM Basic Materials
- Exchange
- PRAX Nasdaq
- SVM Nasdaq
- Market Cap
- PRAX 950.8M
- SVM 1.1B
- IPO Year
- PRAX 2020
- SVM N/A
- Fundamental
- Price
- PRAX $47.08
- SVM $4.57
- Analyst Decision
- PRAX Strong Buy
- SVM Strong Buy
- Analyst Count
- PRAX 10
- SVM 1
- Target Price
- PRAX $102.00
- SVM $6.75
- AVG Volume (30 Days)
- PRAX 578.2K
- SVM 4.7M
- Earning Date
- PRAX 08-04-2025
- SVM 08-07-2025
- Dividend Yield
- PRAX N/A
- SVM 0.55%
- EPS Growth
- PRAX N/A
- SVM N/A
- EPS
- PRAX N/A
- SVM 0.25
- Revenue
- PRAX $7,765,000.00
- SVM $308,064,000.00
- Revenue This Year
- PRAX N/A
- SVM $8.43
- Revenue Next Year
- PRAX $3,567.38
- SVM $27.40
- P/E Ratio
- PRAX N/A
- SVM $18.41
- Revenue Growth
- PRAX 338.45
- SVM 35.50
- 52 Week Low
- PRAX $26.70
- SVM $2.87
- 52 Week High
- PRAX $91.83
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- PRAX 42.83
- SVM 50.62
- Support Level
- PRAX $44.25
- SVM $4.49
- Resistance Level
- PRAX $49.97
- SVM $4.67
- Average True Range (ATR)
- PRAX 3.36
- SVM 0.18
- MACD
- PRAX -0.89
- SVM -0.01
- Stochastic Oscillator
- PRAX 18.84
- SVM 54.39
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.